Molecular characterization,immunocorrelation analysis,WGCNA analysis and machine learning modeling of genes associated with copper death subtypes of laryngeal cancer
Restricted accessResearch articleFirst published online November, 2024
Molecular characterization,immunocorrelation analysis,WGCNA analysis and machine learning modeling of genes associated with copper death subtypes of laryngeal cancer
Laryngeal cancer is a malignant tumor that originates from the mucous membrane of the larynx. Currently, the specific involvement mechanism of copper death in laryngeal cancer patients has not been deeply studied.
OBJECTIVE:
This study aims to explore the molecular characteristics and clinical survival significance of copper death-related genes in laryngeal cancer.
METHODS:
Relevant transcriptomes and clinical data were retrieved and downloaded from the GEO database. Differential expression genes related to laryngeal cancer and copper death were selected, and the immune function, clinical risk correlation, and survival prognosis were analyzed.
RESULTS:
The differential analysis results showed that the differential expression genes related to laryngeal cancer and Cu-proptosis included SLC31A1 and ATP7B, and there was interaction between the immune cell groups in the differential genes of copper death in laryngeal cancer. Decreasing the expression of the gene ANXA5 or increasing the expression of the gene SERPINH1 can increase the susceptibility to laryngeal cancer.
CONCLUSION:
Copper death-related genes can affect the survival prognosis of laryngeal cancer patients. Detection of changes in their expression can provide new diagnostic and treatment directions for the progression of early-stage laryngeal cancer.
WangJYZhangQWWenKWangCJiXZhangL. Temporal trends in incidence and mortality rates of laryngeal cancer at the global, regional and national levels, 1990–2017. BMJ Open.2021; 11(10): e050387. doi: 10.1136/bmjopen-2021-050387.
2.
LechienJRManiaciAHansSIannellaGFakhryNMayo-YáñezM, et al. Epidemiological, clinical and oncological outcomes of young patients with laryngeal cancer: A systematic review. Eur Arch Otorhinolaryngol.2022; 279(12): 5741-5753. doi: 10.1007/s00405-022-07466-9.
KuperHBoffettaPAdamiHO. Tobacco use and cancer causation: Association by tumour type. J Intern Med.2002; 252(3): 206-24. doi: 10.1046/j.1365-2796.2002.01022.x.
5.
Salvador-ColomaCCohenE. Multidisciplinary care of laryngeal cancer. J Oncol Pract.2016; 12(8): 717-24. doi: 10.1200/JOP.2016.014225.
6.
Brandstorp-BoesenJSørum FalkRFolkvard EvensenJBoysenMBrøndboK. Risk of recurrence in laryngeal cancer. PLoS One.2016; 11(10): e0164068. doi: 10.1371/journal.pone.0164068.
7.
NankivellPWellerMMcConkeyCPaleriVMehannaH. Biomarkers in laryngeal dysplasia: A systematic review. Head Neck.2011; 33(8): 1170-6. doi: 10.1002/hed.21592.
8.
JeannonJPSoamesJVAstonVStaffordFWWilsonJA. Molecular markers in dysplasia of the larynx: Expression of cyclin-dependent kinase inhibitors p21, p27 and p53 tumour suppressor gene in predicting cancer risk. Clin Otolaryngol Allied Sci.2004; 29(6): 698-704. doi: 10.1111/j.1365-2273.2004.00859.x.
9.
BrautTKujundzicMVukelicJManestarDKrstuljaMStarcevicR, et al. Gene amplification of epidermal growth factor receptor in atypical glottic hyperplasia. Coll Antropol.2012; 36(2): 87-91.
10.
LiLHanJZhangSDongCXiaoX. KIF26B-AS1 regulates TLR4 and activates the TLR4 signaling pathway to promote malignant progression of laryngeal cancer. J Microbiol Biotechnol.2022; 32(10): 1344-1354. doi: 10.4014/jmb.2203.03037.
11.
GongLWangXFLiuHLiL. MiRNA-106a-5p Promotes Laryngeal Carcinoma Proliferation and Migration Through PI3K/AKT/m-TOR Pathway by AKTIP. Iran J Biotechnol.2023; 21(1): e3339. doi: 10.30498/ijb.2022.336501.3339.
12.
TsvetkovPCoySPetrovaBDreishpoonMVermaAAbdusamadM, et al. Copper induces cell death by targeting lipoylated TCA cycle proteins. Science.2022; 375(6586): 1254-1261. doi: 10.1126/science.abf0529.
13.
BockFJTaitSWG. Mitochondria as multifaceted regulators of cell death. Nat Rev Mol Cell Biol.2020; 21(2): 85-100. doi: 10.1038/s41580-019-0173-8.
14.
TsvetkovPDetappeACaiKKeysHRBruneZYingW, et al. Mitochondrial metabolism promotes adaptation to proteotoxic stress. Nat Chem Biol.2019; 15(7): 681-689. doi: 10.1038/s41589-019-0291-9.
15.
GeEJBushAICasiniACobinePACrossJRDeNicolaGM, et al. Connecting copper and cancer: From transition metal signalling to metalloplasia. Nat Rev Cancer.2022; 22(2): 102-113. doi: 10.1038/s41568-021-00417-2.
16.
AckermanCMLeeSChangCJ. Analytical methods for imaging metals in biology: From transition metal metabolism to transition metal signaling. Anal Chem.2017; 89(1): 22-41. doi: 10.1021/acs.analchem.6b04631.
17.
LopezJRamchandaniDVahdatL. Copper Depletion as a Therapeutic Strategy in Cancer. Met Ions Life Sci. 2019; 19. doi: 10.1515/9783110527872-018.
18.
FountzilasEMarkouKVlachtsisKNikolaouAArapantoni-DadiotiPNtoulaE, et al. Identification and validation of gene expression models that predict clinical outcome in patients with early-stage laryngeal cancer. Ann Oncol.2012; 23(8): 2146-2153. doi: 10.1093/annonc/mdr576.
19.
FountzilasEKotoulaVAngouridakisNKarasmanisIWirtzRMEleftherakiAG, et al. Identification and validation of a multigene predictor of recurrence in primary laryngeal cancer. PLoS One.2013; 8(8): e70429. doi: 10.1371/journal.pone.0070429.
20.
SeilerMHuangCCSzalmaSBhanotG. ConsensusCluster: A software tool for unsupervised cluster discovery in numerical data. OMICS.2010; 14(1): 109-13. doi: 10.1089/omi.2009.0083.
21.
RichJTNeelyJGPanielloRCVoelkerCCNussenbaumBWangEW. A practical guide to understanding Kaplan-Meier curves. Otolaryngol Head Neck Surg.2010; 143(3): 331-6. doi: 10.1016/j.otohns.2010.05.007.
22.
HänzelmannSCasteloRGuinneyJ. GSVA: Gene set variation analysis for microarray and RNA-seq data. BMC Bioinformatics.2013; 14: 7. doi: 10.1186/1471-2105-14-7.
23.
NewmanAMLiuCLGreenMRGentlesAJFengWXuY, et al. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods.2015; 12(5): 453-7. doi: 10.1038/nmeth.3337.
24.
YangYLiLZhengYLiuQWeiXGongX, et al. A prospective, single-arm, phase II clinical trial of intraoperative radiotherapy using a low-energy X-ray source for local advanced Laryngocarcinoma (ILAL): A study protocol. BMC Cancer.2020; 20(1): 734. doi: 10.1186/s12885-020-07233-1.
25.
HoggGEThompsonCSGAsimakopoulosPHayANixonIJ. Is elective contralateral neck dissection necessary in 53 salvage total laryngectomy patients? Clin Otolaryngol.2021; 46(4): 841-845. doi: 10.1111/coa.13693.
26.
TawfikGMMakramOMZayanAHGhozySEidPSMahmoudMH, et al. Voice rehabilitation by voice prostheses after total laryngectomy: A systematic review and network meta-analysis for 11,918 patients. J Speech Lang Hear Res.2021; 64(7): 2668-2681. doi: 10.1044/2021_JSLHR-20-00597.
27.
YamazakiHSuzukiGAibeNShiomiHOhRJYoshidaK, et al. Reirradiation for local recurrence of oral, pharyngeal, and laryngeal cancers: A multi-institutional study. Sci Rep.2023; 13(1): 3062. doi: 10.1038/s41598-023-29459-2.
28.
ZhangHChenZHuangQGuoYWangMWuC. Preliminary study using a small plasma extracellular vesicle miRNA panel as a potential biomarker for early diagnosis and prognosis in laryngeal cancer. Cell Oncol (Dordr).2023; 46(4): 1015-1030. doi: 10.1007/s13402-023-00792-y.
29.
LiuHTangT. Pan-cancer genetic analysis of cuproptosis and copper metabolism-related gene set. Front Oncol.2022; 12: 952290. doi: 10.3389/fonc.2022.952290.
30.
SpahićLKurtaECordicSBecirovicMGurbetaLKovacevicZ, et al. Machine Learning Techniques for Performance Prediction of Medical Devices: Infant Incubators. Cmbebih 2019. IFMBE Proceedings. 2020; 483-90.
31.
BadnjevicACifrekMKorugaD. Classification of Chronic Obstructive Pulmonary Disease (COPD) Using Integrated Software Suite. IFMBE XIII Mediterranean Conference on Medical and Biological Engineering and Computing 2013At: Seville, Spain. September 2013; 41(41). doi: 10.1007/978-3-319-00846-2_225.
32.
HrvatFSpahicLGurbeta PokvicLBadnjevicA. Artificial Neural Networks for prediction of medical device performance based on conformity assessment data: Infusion and perfusor pumps case study. 9th Mediterranean Conference on Embedded Computing MECO’2020. June 2020.
33.
VeljovicESpirtovic-HalilovicSMuratovicSOsmanovicABadnjevicA, et al. Artificial Neural Network and Docking Study in Design and Synthesis of Xanthenes as Antimicrobial Agents. March 2017. IFMBE proceedings. 2017; 617-626. doi: 10.1007/978-981-10-4166-2_93.
34.
HafizovićLČauševićADeumićABećirovićLSPokvićLGBadnjevićA. The Use of Artificial Intelligence in Diagnostic Medical Imaging: Systematic Literature Review. 2021 IEEE 21st International Conference on Bioinformatics and Bioengineering (BIBE). October 2021. doi: 10.1109/BIBE52308.2021.9635307.
35.
KongFSRenCYJiaRZhouYChenJHMaY. Systematic pan-cancer analysis identifies SLC31A1 as a biomarker in multiple tumor types. BMC Med Genomics.2023; 16(1): 61. doi: 10.1186/s12920-023-01489-9.
36.
YoshizawaKNozakiSKitaharaHOharaTKatoKKawashiriS, et al. Copper efflux transporter (ATP7B) contributes to the acquisition of cisplatin-resistance in human oral squamous cell lines. Oncol Rep.2007; 18(4): 987-91.
37.
HanXChengXDaiKBaoWDingRWanY. Identification of immunocell infiltrates and effective diagnostic biomarkers in laryngeal carcinoma. Medicine (Baltimore).2023; 102(3): e32548. doi: 10.1097/MD.0000000000032548.
38.
ZhaoYSunJLiangYJiangXTangXSunY, et al. Increased expression of ST2 on regulatory T cells is associated with cancer associated fibroblast-derived IL-33 in laryngeal cancer. Pathol Res Pract.2022; 237: 154023. doi: 10.1016/j.prp.2022.154023.
39.
de Lima-SouzaRAScariniJFLavarezeLEmerickCDos SantosESPaes LemeAF, et al. Protein markers of primary salivary gland tumors: A systematic review of proteomic profiling studies. Arch Oral Biol.2022; 136: 105373. doi: 10.1016/j.archoralbio.2022.105373.
40.
CaiLWangYPengXLiWYuanYTaoX, et al. Gold nanostars combined with the searched antibody for targeted oral squamous cell carcinoma therapy. ACS Biomater Sci Eng.2022; 8(6): 2664-2675. doi: 10.1021/acsbiomaterials.2c00276.
